Assenagon Asset Management’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-744,282
Closed -$8.29M 1364
2024
Q3
$8.29M Buy
+744,282
New +$8.2M 0.02% 581
2022
Q2
Sell
-398,205
Closed -$4.32M 1496
2022
Q1
$4.32M Buy
398,205
+160,111
+67% +$1.94M 0.01% 562
2021
Q4
$3.35M Sell
238,094
-745,743
-76% -$12.3M 0.01% 631
2021
Q3
$18.9M Buy
+983,837
New +$13.1M 0.06% 216
2019
Q2
Sell
-104,000
Closed -$760K 1038
2019
Q1
$760K Buy
+104,000
New +$1.02M 0.01% 745

Other funds holding DVAX

Assenagon Asset Management's DVAX Position: Q4 2024 in Review

Assenagon Asset Management sold out of Dynavax Technologies (DVAX) in Q4 2024, closing a stake of 744,282 shares — an estimated $8.29M sold.

Assenagon Asset Management first reported a position in DVAX in Q1 2019 and held it in 5 quarters. The position peaked at $18.9M in Q3 2021. 256 funds tracked by Wall St. Rank hold DVAX as of Q4 2024.

  • Assenagon Asset Management reported no remaining Dynavax Technologies position as of Q4 2024 after selling out during the quarter.
  • Assenagon Asset Management sold 744,282 Dynavax Technologies shares in Q4 2024, an estimated $8.29M.
  • Assenagon Asset Management first reported a position in Dynavax Technologies in Q1 2019 and held it in 5 quarters.
  • Assenagon Asset Management's Dynavax Technologies position peaked at $18.9M in Q3 2021.
  • 256 funds tracked by Wall St. Rank held Dynavax Technologies as of Q4 2024.

Based on Assenagon Asset Management's 13F filing for Q4 2024, filed 14 Jan 2025.